[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention]
- PMID: 963962
[Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention]
Similar articles
-
[Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].Schweiz Rundsch Med Prax. 1975 Nov 4;64(44):1414-7. Schweiz Rundsch Med Prax. 1975. PMID: 1236699 German. No abstract available.
-
[Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].Minerva Med. 1986 Jan 28;77(3-4):87-91. Minerva Med. 1986. PMID: 3511409 Clinical Trial. Italian.
-
[Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):255-61. Minerva Dietol Gastroenterol. 1984. PMID: 6504374 Italian. No abstract available.
-
Diuretics in edema: how they work; how to pick the best one.Med Times. 1972 Mar;100(3):86-102. Med Times. 1972. PMID: 4559278 Review. No abstract available.
-
[Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].Naika. 1969 Nov;24(5):834-9. Naika. 1969. PMID: 4902224 Review. Japanese. No abstract available.